logo
Select company
Select metric
$ -171.48MNet Cash Flow - Operations
VS
Market
3
Sector
8
Industry
13
History
7
$ 17.38Close
$ 7.8 - $ 29.6 52-Week Range
Ticker Information

Ticker

LYEL

Company Name

LYELL IMMUNOPHARMA INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

LYELL IMMUNOPHARMA INC - Net Cash Flow - Operations Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

LYEL - CF - Operations Historical data
DateNet Cash Flow - Operations
6/30/2025$ -171.48M
3/31/2025$ -175.12M
12/31/2024$ -162.39M
9/30/2024$ -155.79M
6/30/2024$ -158.43M
3/31/2024$ -159.5M
12/31/2023$ -163.69M
9/30/2023$ -163.33M
6/30/2023$ -162.74M
3/31/2023$ -167.91M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • LYELL IMMUNOPHARMA INC's latest trailing twelve months (TTM) CF - Operations stands at $ -160.87M.
  • Over the past 5 years, LYELL IMMUNOPHARMA INC's average CF - Operations has been $ -159.43M.
  • The median CF - Operations for LYELL IMMUNOPHARMA INC during this period was $ -162.43M
  • LYELL IMMUNOPHARMA INC reached its highest CF - Operations over the past 5 years at $ -126.25M.
  • The lowest CF - Operations recorded by LYELL IMMUNOPHARMA INC in the same timeframe $ -175.12M

LYELL IMMUNOPHARMA INC's CF - Operations vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Operations Benchmarks
CompanyCF - Operations
FDMT : 4D MOLECULAR THERAPEUTICS INC $ -166.39MINMB : INMUNE BIO INC $ -32.2MHYPD : HYPERION DEFI INC $ -19.94MEPRX : EUPRAXIA PHARMACEUTICALS INC $ -30.48MVOR : VOR BIOPHARMA INC $ -113.6MTVGN : TEVOGEN BIO HOLDINGS INC $ -13.35MCRGX : CARGO THERAPEUTICS INC $ -189.59MCURX : CURANEX PHARMACEUTICALS INC -MNPR : MONOPAR THERAPEUTICS $ -9.81MTIL : INSTIL BIO INC $ -49.68M

Definition of Net Cash Flow - Operations

[Cash Flow Statement] Cash flow from operations represents the amount of cash inflow (outflow) that a company generates (consumes) from operating activities. Similar to Net Income [NetIncCmn] but harder to manipulate and ignoring effects of non-cash charges like depreciation.

LYEL - Net Cash Flow - Operations, Last 5 years

$ -175.12M

Minimum

Mar 31, 2025

$ -126.25M

Maximum

Dec 31, 2021

$ -159.43M

Average

$ -162.43M

Median

CF - Operations Benchmark Analysis

The chart above depicts the distribution of CF - Operations for companies in the Total Stock Market. The average CF - Operations of the companies is $ 57.96M with a standard deviation of $ 141.66M.
The following table provides additional summary stats:
CF - Operations in the Market:
filtered constituents3.26K
min$ -406M
max$ 506.5M
average$ 57.96M
median$ 10.78M
std$ 141.66M